Subscribe To
Allakos presents preclinical data at eaaci hybrid congress 2023 highlighting lirentelimab and ak006 mechanisms of mast cell inhibition
– AK006 inhibits IgE mediated mast cell activation and shows similar IgE inhibitory activity as remibrutinib –– AK006 also inhibits non-IgE mast...
June 12, 2023, 11:02 am
Allakos announces upcoming presentation on lirentelimab and ak006 mast cell inhibition at the european academy of allergy and clinical immunology (eaaci) hybrid congress 2023
SAN CARLOS, Calif., June 05, 2023 (GLOBE NEWSWIRE) — Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics whi...
June 5, 2023, 11:02 am
effector therapeutics announces closing of $7.5 million registered direct offering priced at-the-market under nasdaq rules
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 31, 2023 (GLOBE NEWSWIRE) — effector Therapeutics,...
May 31, 2023, 9:43 pm
Why is effector therapeutics (eftr) stock up 75% today?
effector Therapeutics (NASDAQ: EFTR ) stock is taking off on Friday after the company reported positive...
May 26, 2023, 8:28 am
effector therapeutics reports positive data updates from phase 2 expansion cohorts evaluating zotatifin in patients with er+ metastatic breast cancer at the asco 2023 annual meeting
Partial responses observed in 5 of 19 (26%) evaluable patients treated with zotatifin 0.07 mg/kg combined with fulvestrant and abemaciclib (ZFA triple...
May 25, 2023, 8:50 pm
Aerospace robotics market to reach usd 31.58 billion by 2030, at a cagr of 11.7% – report by market research future
Aerospace Robotics Market Research Report Information By Type (Traditional Robots[Articulated, Parallel, Linear/Cartesian, Scara, and Others], and Col...
May 20, 2023, 3:47 pm
Cabaletta bio to present at the american society of gene and cell therapy 26th annual meeting
PHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and la...
May 2, 2023, 4:35 pm
effector therapeutics to participate in upcoming investor conferences
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- effector Therapeutics...
March 28, 2023, 8:30 am
effector therapeutics to present at 2023 bio ceo & investor conference
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- effector Therapeutics,...
January 30, 2023, 8:00 am
Poseida therapeutics to present early data from phase 1 trials of p-muc1c-allo1 and p-bcma-allo1 at esmo immuno-oncology 2022 annual congress
P-MUC1C-ALLO1 and P-BCMA-ALLO1 were well tolerated, with no dose-limiting toxicities (DLTs), cytokine release syndrome (CRS), graft vs host disease (G...
December 6, 2022, 6:00 am
Medgene therapeutics publishes preclinical data demonstrating riv-8’s ability to overcome t cell exhaustion in the journal science advances
RIV-8 is a breakthrough technology to address T cell exhaustion GAITHERSBURG, Md., Nov. 29, 2022 (GLOBE NEWSWIRE) — MedGene Therapeutics, Inc. (MedG...
November 29, 2022, 10:00 pm
Tiziana life sciences publishes peer-reviewed research, showing intranasal administered drug for autoimmune diseases is safe in humans
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it has published a scientific article in the peer-reviewed journal Frontiers in Immunology, showing a fav...
November 23, 2022, 11:41 am
4 stocks under $2 insiders are aggressively buying: nexgel, effector therapeutics and more
U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades....
June 28, 2022, 7:58 am
Shattuck labs to present two posters at the 2022 american association for cancer research (aacr) annual meeting
AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology compa...
March 9, 2022, 8:21 am
effector therapeutics to present at 2022 bio ceo & investor conference
SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- effector Therapeutics (NASDAQ: EF...
February 9, 2022, 4:00 pm
effector therapeutics to present at 2022 bio ceo & investor conference
SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- effector Therapeutics (NASDAQ: EF...
February 9, 2022, 4:00 pm
effector therapeutics to present at 2022 bio ceo & investor conference
SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- effector Therapeutics (NASDAQ: EF...
February 9, 2022, 4:00 pm
Caci debuts two new counter-unmanned aircraft system technologies
RESTON, Va.--(BUSINESS WIRE)--CACI International Inc (NYSE: CACI) announced today the release of its latest technologies to mitigate threats from unma...
October 11, 2021, 8:57 am
Caci debuts two new counter-unmanned aircraft system technologies
RESTON, Va.--(BUSINESS WIRE)--CACI International Inc (NYSE: CACI) announced today the release of its latest technologies to mitigate threats from unma...
October 11, 2021, 8:57 am
Caci debuts two new counter-unmanned aircraft system technologies
RESTON, Va.--(BUSINESS WIRE)--CACI International Inc (NYSE: CACI) announced today the release of its latest technologies to mitigate threats from unma...
October 11, 2021, 8:57 am